• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Diclofenac - Key patent, SPC, and data exclusivity expiry (7 country coverage) Product Image

Diclofenac - Key patent, SPC, and data exclusivity expiry (7 country coverage)

  • ID: 1532321
  • October 2014
  • Genericsweb Pty Ltd – Ark Patent Intelligence

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country coverage also available), regulatory issues and key players.

This Pipeline Selector report covers Diclofenac
Diclofenac indications: Antiinflammatory; Acute pain states; Acute migraine (with or without aura); Symptomatic treatment of primary dysmenorrhoea; Temporary relief of symptoms of colds and flu; Fever reduction; Rheumatoid arthritis & osteoarthritis
Diclofenac innovator: Novartis (Cataflam, Voltaren, Voltfast, Veejay Gel); Church and Dwight (Dencorub); Ciba Vision (Voltaren); Inst Biochem (Flector); Nycomed (Solaraze); Nuvo (Pennsaid); Pfizer (Arthrotec)

Examples of information found in this online report include:
- Includes key patent publications for 7 countries (see list below)
- Contains SPC protection for every EU state plus patent term extensions in other countries
- Data exclusivity calculated on a country by country basis
- Summary of dosage forms, strengths, indications and active ingredient forms of the brand product
- READ MORE >

Novartis (Cataflam, Voltaren, Voltfast, Veejay Gel); Church and Dwight (Dencorub); Ciba Vision (Voltaren); Inst Biochem (Flector); Nycomed (Solaraze); Nuvo (Pennsaid); Pfizer (Arthrotec)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos